HUT64082A - Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient - Google Patents
Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredientInfo
- Publication number
- HUT64082A HUT64082A HU9300901A HU9300901A HUT64082A HU T64082 A HUT64082 A HU T64082A HU 9300901 A HU9300901 A HU 9300901A HU 9300901 A HU9300901 A HU 9300901A HU T64082 A HUT64082 A HU T64082A
- Authority
- HU
- Hungary
- Prior art keywords
- active ingredient
- same
- pharmaceutical compositions
- steroid derivatives
- producing steroid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0029—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0011—Unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85890892A | 1992-03-27 | 1992-03-27 | |
US1898593A | 1993-03-03 | 1993-03-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9300901D0 HU9300901D0 (en) | 1993-06-28 |
HUT64082A true HUT64082A (en) | 1993-11-29 |
Family
ID=26691704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9300901A HUT64082A (en) | 1992-03-27 | 1993-03-26 | Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0562849A2 (hu) |
JP (1) | JPH0656670A (hu) |
CN (1) | CN1081682A (hu) |
AU (1) | AU3551493A (hu) |
BR (1) | BR9301342A (hu) |
CA (1) | CA2092766A1 (hu) |
CZ (1) | CZ50593A3 (hu) |
FI (1) | FI931373A (hu) |
HU (1) | HUT64082A (hu) |
IL (1) | IL105050A0 (hu) |
MX (1) | MX9301653A (hu) |
NO (1) | NO931117L (hu) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2724174B1 (fr) | 1994-09-06 | 1997-01-17 | Roussel Uclaf | Procede de preparation d'un derive steroide 17beta-carboxy et nouveaux intermediaires |
NZ335974A (en) * | 1996-11-28 | 2000-06-23 | Henkel Kgaa | Hypocholesteremic agents containing tocopherols and phytostanol (phytosterols) |
CN1063449C (zh) * | 1996-12-27 | 2001-03-21 | 中国科学院广州化学研究所 | 一种胆甾醇化合物及其提取方法 |
JP3873097B2 (ja) * | 1997-11-06 | 2007-01-24 | 独立行政法人理化学研究所 | 抗肥満剤及び脂質代謝改善剤 |
US6531462B2 (en) | 1997-11-06 | 2003-03-11 | Riken | Medicament for treating obesity and improving lipid metabolism |
US6093389A (en) * | 1997-12-01 | 2000-07-25 | American Cyanamid Company | Methods and compositions for attracting and controlling termites |
GB9804861D0 (en) | 1998-03-06 | 1998-04-29 | Res Inst Medicine Chem | Chemical compounds |
US6579862B1 (en) | 1999-01-12 | 2003-06-17 | Council Of Scientific & Industrial Research | Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones |
US20070197484A1 (en) * | 2001-05-03 | 2007-08-23 | Ching Song | Method of treating disorder related to high cholesterol concentration |
DK1392713T3 (da) * | 2001-05-03 | 2008-02-18 | Univ Chicago | Lever-X-receptoragonister |
US7078396B2 (en) | 2001-05-03 | 2006-07-18 | Arch Development Corporation | Method of treating disorder related to high cholesterol concentration |
EP1450816A4 (en) * | 2001-11-08 | 2008-02-13 | Univ Chicago | METHOD FOR TREATING DISORDER IN CONNECTION WITH INCREASED CHOLESTERITE CONCENTRATION |
AU2002356919B2 (en) * | 2001-11-08 | 2008-04-17 | The University Of Chicago | Method of treating disorder related to high cholesterol concentration |
US20110190323A1 (en) | 2008-08-28 | 2011-08-04 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses thereof |
CA2769203A1 (en) | 2009-07-29 | 2011-02-03 | University Of Chicago | Liver x receptor agonists |
JP2015509538A (ja) * | 2012-03-07 | 2015-03-30 | リガンド・ファーマシューティカルズ・インコーポレイテッド | 1つに統合された恒常性システムとしてのステロイドホルモン経路およびコレステロール経路 |
EP3505521A1 (en) | 2013-12-24 | 2019-07-03 | President and Fellows of Harvard College | Cortistatin analogues and syntheses and uses thereof |
EP3294298A4 (en) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin analogues, syntheses, and uses thereof |
EP3316889A4 (en) | 2015-07-01 | 2018-11-14 | President and Fellows of Harvard College | Cortistatin analogues and syntheses and uses thereof |
US9637514B1 (en) | 2015-10-26 | 2017-05-02 | MAX BioPharma, Inc. | Oxysterols and hedgehog signaling |
CN111973606B (zh) * | 2019-05-22 | 2023-05-12 | 王伟 | 一种化合物治疗血管增生以及糖尿病视网膜病变的新用途 |
WO2023143399A1 (zh) * | 2022-01-28 | 2023-08-03 | 珂阑(上海)医药科技有限公司 | 甾类化合物、其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH372297A (de) * | 1959-02-10 | 1963-10-15 | Ciba Geigy | Verfahren zur Herstellung von 4-2-tert.-Aminomethyl-3-keto-steroiden |
US3256302A (en) * | 1960-10-20 | 1966-06-14 | Parke Davis & Co | 2-hydroxymethylene-17alpha-ethinyl-17beta-hydroxy-19-nor-4-androsten-3-one |
US3314977A (en) * | 1962-06-18 | 1967-04-18 | Searle & Co | Optionally 17alpha-alkylated 3-oxygenated 2alpha-dialkylaminomethyl-5alpha-androstan-17beta-ols and esters thereof |
GB1015214A (en) * | 1963-03-11 | 1965-12-31 | Merck Ag E | Cholesterol derivatives and preparation thereof |
US3980638A (en) * | 1974-09-20 | 1976-09-14 | The Upjohn Company | Testosterone derivatives |
CA1113086A (en) * | 1977-08-29 | 1981-11-24 | Robert J. Chorvat | 25-alkylcholesterol derivatives |
US4297350A (en) * | 1978-10-10 | 1981-10-27 | The Upjohn Company | Male contraceptive steroids and methods of use |
JP2550777B2 (ja) * | 1990-06-29 | 1996-11-06 | 日立化成工業株式会社 | ステロイドケトン系化合物,その製造法,非線形光学材料および非線形光学素子 |
-
1993
- 1993-03-15 IL IL105050A patent/IL105050A0/xx unknown
- 1993-03-24 MX MX9301653A patent/MX9301653A/es unknown
- 1993-03-24 EP EP93302261A patent/EP0562849A2/en not_active Withdrawn
- 1993-03-25 NO NO93931117A patent/NO931117L/no unknown
- 1993-03-25 CZ CZ93505A patent/CZ50593A3/cs unknown
- 1993-03-26 JP JP5067968A patent/JPH0656670A/ja not_active Withdrawn
- 1993-03-26 HU HU9300901A patent/HUT64082A/hu unknown
- 1993-03-26 CN CN93105203A patent/CN1081682A/zh active Pending
- 1993-03-26 CA CA002092766A patent/CA2092766A1/en not_active Abandoned
- 1993-03-26 FI FI931373A patent/FI931373A/fi not_active Application Discontinuation
- 1993-03-26 AU AU35514/93A patent/AU3551493A/en not_active Abandoned
- 1993-03-29 BR BR9301342A patent/BR9301342A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1081682A (zh) | 1994-02-09 |
NO931117D0 (no) | 1993-03-25 |
FI931373A0 (fi) | 1993-03-26 |
AU3551493A (en) | 1993-09-30 |
FI931373A (fi) | 1993-09-28 |
NO931117L (no) | 1993-09-28 |
CZ50593A3 (en) | 1993-12-15 |
CA2092766A1 (en) | 1993-09-28 |
EP0562849A2 (en) | 1993-09-29 |
MX9301653A (es) | 1994-02-28 |
JPH0656670A (ja) | 1994-03-01 |
BR9301342A (pt) | 1993-10-05 |
HU9300901D0 (en) | 1993-06-28 |
IL105050A0 (en) | 1993-07-08 |
EP0562849A3 (hu) | 1994-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT64065A (en) | Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT64082A (en) | Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT59106A (en) | Process for producing 3-amidopyrazoles and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT52089A (en) | Process for producing triazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT56270A (en) | Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT51222A (en) | Process for producing 9-halogen-/z/-prostaglandin derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT46654A (en) | Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient | |
HUT60466A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT59145A (en) | Process for producing substituted azole derivatives and pharmaceutical compositions such compounds as active ingredient | |
HUT63632A (en) | Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same | |
HUT49625A (en) | Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient | |
HUT53646A (en) | Process for producing pteridin-4-(3h)-one derivatives and pharmaceutical compositions comprising such derivatives as active ingredient | |
HUT64013A (en) | Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT59155A (en) | Process for producing corticoid-17-alkylcarbonate derivatives substituted in 17-position and pharmaceutical compositions comprising such derivatives as active ingredient | |
HUT49367A (en) | Process for producing aristeromycin/adenosine derivatives and pharmaceutical compositions comprising same as active ingredient | |
HU9402292D0 (en) | New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component | |
HUT64059A (en) | Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same | |
HUT49598A (en) | Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT59319A (en) | Pharmaceutical compositions with controlled release of active ingredient and process for producing same | |
HUT62593A (en) | Process for producing 3-deoxymannose amine derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT58082A (en) | Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
HUT59116A (en) | Process for producing oxazole derivatives and pharmaceutical compositions comprising oxazole derivatives as active ingredient | |
HUT63415A (en) | Process for producing heterocyclic imidazole derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT47127A (en) | Process for producing pyrimidine derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT59917A (en) | Process for producing sulfonamide derivatives and pharmaceutical compositions containing them as active component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFC4 | Cancellation of temporary protection due to refusal |